AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1

Suitglip-M XR 50/500 Tablet

Prescription Icon
Prescription Required

Marketer

Ipca Laboratories Ltd

Salt Composition

Sitagliptin (50mg) + Metformin (500mg)

Overview Suitglip-M XR 50/500 Tablet

Glimepiride-Metformin extended-release 50/500 mg tablets manage elevated blood glucose in individuals with type 2 diabetes. This dual-action medication mitigates severe diabetic complications like renal impairment and vision loss, potentially lowering cardiovascular event risk. Prescribed independently or in conjunction with other antidiabetic therapies, optimal efficacy requires adherence to a balanced diet and regular physical activity. Dosage is individualized based on your health status, glucose levels, and concurrent medications. Consuming this medication with food minimizes gastrointestinal distress. Consistent daily dosing at the same time maximizes therapeutic benefits; discontinuation should only occur under physician guidance. Continued commitment to the prescribed diet and exercise plan is crucial for effective diabetes management, as lifestyle significantly impacts glucose control. Common adverse effects include diarrhea, nausea, vomiting, dyspepsia, cephalalgia, and pharyngitis. Hypoglycemia, particularly when combined with insulin or sulfonylureas, is a potential risk, necessitating familiarity with its recognition and treatment. This medication isn't universally suitable. Prior to commencing treatment, inform your physician of any pre-existing kidney, liver, or cardiac conditions, pancreatic disorders, or significant alcohol consumption. Pregnant or lactating individuals require medical consultation before use. Potential drug interactions necessitate disclosure of all medications to your doctor to ensure safety. Alcohol should be minimized due to its hypoglycemic effect. Your doctor will monitor kidney function and blood glucose levels throughout treatment.

Uses of Suitglip-M XR 50/500 Tablet

Managing type 2 diabetes

Major Benefits of Suitglip-M XR 50/500 Tablet:

Follow your physician's instructions or consult the product information leaflet for dosage guidance. Consume Suitglip-M XR 50/500 tablets with a meal.

Common Side effects of Suitglip-M XR 50/500 Tablet:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Suitglip-M XR 50/500 Tablet:

Follow your doctor's instructions or the package leaflet for proper administration. Ingest Suitglip-M XR 50/500 Tablets with a meal.

How Suitglip-M XR 50/500 Tablet works:

Suitglip-M XR 50/500 tablets contain sitagliptin and metformin, working synergistically to manage blood glucose levels. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and reduces hepatic glucose output. Metformin, a biguanide, decreases liver glucose production, slows intestinal glucose absorption, and increases insulin sensitivity. This dual action leads to superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Suitglip-M XR 50/500 Tablets with alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Suitglip-M XR 50/500 tablets during pregnancy might pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing this medication. Seek medical advice before taking this drug.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Suitglip-M XR 50/500 tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Suitglip-M XR 50/500 Tablets, potentially requiring dosage modification under medical supervision. This medication is contraindicated in patients with severe kidney disease. Close monitoring of kidney function is recommended during treatment.

LiverLiverUNSAFE

The use of Suitglip-M XR 50/500 tablets is likely inadvisable for individuals with hepatic impairment and should be avoided. Medical advice is recommended.

What if you forget to take Suitglip-M XR 50/500 Tablet :

Should you forget to take a Suitglip-M XR 50/500 Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosage regimen. Avoid taking a double dose.

Facts to Know About Suitglip-M XR 50/500 Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes medication

FAQs on Suitglip-M XR 50/500 Tablet

Suitglip-M XR 50/500 tablets combine sitagliptin and metformin to treat type 2 diabetes in adults. This medication improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Prolonged use of Suitglip-M XR 50/500 Tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency, if left untreated, may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Suitglip-M XR 50/500 Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infection. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Patients with known allergies to Suitglip-M XR 50/500 Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Suitglip-M XR 50/500 tablets with alcohol is unsafe and may raise your risk of lactic acidosis.
Store this medication in its original, tightly closed container as directed on the label or packaging. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Sitagliptin/Metformin (Suitglip-M XR 50/500) can cause lactic acidosis (MALA – Metformin-associated lactic acidosis), a serious medical emergency resulting from excess lactic acid in the blood. This rare side effect necessitates avoiding use in patients with kidney disease, the elderly, or heavy alcohol consumers. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Suitglip-M XR 50/500 tablets combine sitagliptin and metformin to treat type 2 diabetes in adults. This medication improves blood sugar control when used with a healthy diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin boosts insulin release by inhibiting DPP-4. This combination is not suitable for individuals under 18.
Suitglip-M XR 50/500 Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infection. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Suitglip-M XR 50/500 Tablets are contraindicated in patients with known allergies to any ingredient or excipient. Avoid use in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Suitglip-M XR 50/500 Tablet with alcohol is unsafe and may raise your risk of lactic acidosis.
Sitagliptin/Metformin (Suitglip-M XR 50/500) can cause lactic acidosis (MALA), a serious medical emergency resulting from excess blood lactic acid. This rare side effect is more likely in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Prolonged Suitglip-M XR 50/500 Tablet use can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Dispose of any unused medication properly and keep it out of reach of children, pets, and others.
Suitglip-M XR 50/500 Tablets combine sitagliptin and metformin to treat type 2 diabetes in adults. This combination improves blood glucose control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is not suitable for individuals under 18.
Suitglip-M XR 50/500 Tablet may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infection. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Patients with allergies to Suitglip-M XR 50/500 Tablet components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Suitglip-M XR 50/500 tablets with alcohol is unsafe and may raise your risk of lactic acidosis.
Sitagliptin/Metformin (Suitglip-M XR 50/500) can cause lactic acidosis (MALA), a serious, though rare, medical emergency characterized by excess blood lactic acid. This risk is heightened in patients with kidney disease, older adults, and heavy alcohol users, who should avoid this medication. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If these occur, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Prolonged use of Suitglip-M XR 50/500 Tablets can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance issues), urinary problems, and cognitive changes. To mitigate these risks, supplemental vitamin B12 is recommended at least annually.
Store this medication in its original, tightly closed container as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Suitglip-M XR 50/500 Tabl...
85
MRP 99
14% off